Galectin Therapeutics
GALT
#8074
Rank
S$0.22 B
Marketcap
$3.58
Share price
1.48%
Change (1 day)
36.57%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of June 2024 : S$33.34 M

According to Galectin Therapeutics's latest financial reports the company has S$33.34 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$24.92 M-53.39%
2021-12-31S$53.46 M49.01%
2020-12-31S$35.88 M-43.8%
2019-12-31S$63.84 M467.9%
2018-12-31S$11.24 M175.33%
2017-12-31S$4.08 M-81.63%
2016-12-31S$22.23 M-39.24%
2015-12-31S$36.59 M-4.92%
2014-12-31S$38.48 M189.55%
2013-12-31S$13.29 M15.99%
2012-12-31S$11.45 M38.32%
2011-12-31S$8.28 M9.12%
2010-12-31S$7.59 M2052.28%
2009-12-31S$0.35 M-22.86%
2008-12-31S$0.45 M-76.02%
2007-12-31S$1.9 M-78.46%
2006-12-31S$8.85 M19.05%
2005-12-31S$7.43 M-52.89%
2004-12-31S$15.78 M21.9%
2003-12-31S$12.94 M288.42%
2002-12-31S$3.33 M20.76%
2001-12-31S$2.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.27 B 3,714.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.32 B 867.89%๐Ÿ‡บ๐Ÿ‡ธ USA